Startups
Biotron is developing first-in-class drugs to serious viral diseases. Its lead compound BIT225 is in Phase 2 trials for treatment of HIV and Hepatitis C virus.
Overview
Location
Australia, New South Wales, Sydney
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 19, 2024 | Significant | significant.vc |
Mentions in press and media 1
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
Reviews 0
FAQ about Biotron Limited
Who has invested in Biotron Limited?
Parsers VC lists 2 investors of Biotron Limited, among them Significant.
Is Biotron Limited still active?
Yes, Biotron Limited is active; its latest activity on Parsers VC dates from Jun 19, 2024.